Carl Zeiss Meditec company profile
Company profile
Carl Zeiss Meditec has 5,784 employees and is headquartered in Jena, Germany.
With revenue of EUR 2.2 billion in the fiscal year ended September 2025, Carl Zeiss Meditec AG is a medical technology company whose activities are split between two segments, Ophthalmology and Microsurgery. The Ophthalmology business supplies instruments for diagnosing and treating chronic eye diseases, from slit lamps and optical coherence tomography systems to surgical microscopes, intraocular lenses and laser eye surgery equipment. The Microsurgery segment offers surgical visualization, intraoperative radiotherapy and pathology, special instruments and digital solutions for minimally invasive procedures. Its customers are physicians across specialties and hospitals, and it sells in Germany, the rest of Europe, North America and Asia.
In the fiscal year ended September 2025, net income came to EUR 141.2 million, while revenue grew 7.8% year on year. The company employed 5,784 people and is headquartered in Jena, Germany, where it was founded in 1846. It is a subsidiary of ZEISS Group and has a strategic collaboration with Envision Health Technologies Inc. to advance glaucoma care through gamified virtual reality.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Germany
- Headquarters
- Göschwitzer Straße 51-52, 07745, Jena
- Employees
- 5,784
- Chief executive
- Andreas Pecher
- Founded
- 1846
- Fiscal year
- October - September
- Listing
- AFX · Xetra
- Currency
- EUR
- ISIN
- DE0005313704
Carl Zeiss Meditec and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Carl Zeiss MeditecAFX | Germany | $3.37B | 5,784 | 7.2% | 25.2 |
| Tecan GroupTECN | Switzerland | $3.65B | 3,000 | 4.9% | — |
| SCHOTT Pharma1SXP | Germany | $3.69B | 5,002 | 16.4% | 24.8 |
| OttobockOBCK | Germany | $2.82B | 8,606 | 18.7% | 19.9 |
| Fielmann GroupFIE | Germany | $4.05B | 18,213 | 13.7% | 16.9 |
| AddLifeALIF.B | Sweden | $2.19B | 2,428 | 8.9% | 34.4 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
